Extremely significant negative changes in Integra LifeSciences Holdings Co (NASDAQ: IART) investment behavior have recently occurred: negative upside/downside volume developed, and its shorter term price trend turned down.
Recent meaningful negative changes in fundamentals have affected Integra LifeSciences Holdings Co (NASDAQ: IART): significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Integra LifeSciences Holdings has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Integra LifeSciences Holdings has a slightly positive Appreciation Score of 66 and a neutral Power Rating of 41, resulting in the Neutral Value Trend Rating.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock declined modestly by -1.7% on 4/1/25. The stock closed at $21.61. However, this decline was accompanied by below average trading volume at 75% of normal. The stock has declined -4.5% during the last week and has performed in line with the market over the last nine months.
Be the first to comment